Page last updated: 2024-11-01

nomifensine and Bile Duct Obstruction

nomifensine has been researched along with Bile Duct Obstruction in 2 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dawson, S1
Stahl, S1
Paul, N1
Barber, J1
Kenna, JG1
Brandes, JW1
Körst, HA1
Littmann, KP1

Other Studies

2 other studies available for nomifensine and Bile Duct Obstruction

ArticleYear
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters

2012
[Jaundice following nomifensine].
    Die Medizinische Welt, 1980, Oct-31, Volume: 31, Issue:44

    Topics: Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Female; Humans; Isoquinoli

1980